CS logo
small CS logo
Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi

Izmir, Turkey
Hospital in İzmir
Yenişehir, Gaziler Cd No - 331 D - 28, 35170 Konak/İzmir

About Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Hoffmann-La Roche
4
Total Rows: 2

Clinical Trials at Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi


During the past decade, Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100000000221100000022110011Started TrialsCompleted Trails20152016201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis
2012-06-06
2021-02-01
Completed
752
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
Nintedanib (BIBF 1120) in Mesothelioma
2013-09-19
2018-08-31
Terminated
545
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
2013-11-26
2016-10-27
Completed
113
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
2015-07-20
2022-03-08
Completed
572
A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung Cancer
2020-03-04
2025-02-21
Recruiting
660
A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19
2020-12-16
2022-07-25
Terminated
104

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 5Boehringer Ingelheim: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi


According to Clinical.Site data, the most researched conditions in "Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Asthma" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Mesothelioma" (1 trials). Many other conditions were trialed in "Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi" in a lesser frequency.

Clinical Trials Intervention Types at Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi


Most popular intervention types in "Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi" are "Drug" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Nintedanib" (3 trials), "Cisplatin" (2 trials), "Matching Placebo" (2 trials), "Pemetrexed" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi


The vast majority of trials in "Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi" are 9 trials for "All" genders.

Clinical Trials Status at Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi


Currently, there are NaN active trials in "Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Izmir Dr. Suat Seren Gogus Hastaliklari ve Cerrahisi Egitim ve Arastirma Hastanesi, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 8Phase 3: 8Phase 2: 2Phase 2: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Recruiting: 2Recruiting: 2Terminated: 2Terminated: 2